Compared with SNRA, SPRA was linked to a 29% higher risk of pneumonia and a 58% higher risk of hospitalization. Researchers noted that seropositivity may reflect greater systemic inflammation and ...
Despite an executive order aimed at addressing homelessness in the US, defunding vital programs could spell difficulty in helping the homeless.
Primary aldosteronism is often overlooked in hypertension. Educating providers and utilizing tools can enhance screening and treatment effectiveness, emphasizes Vivek Bhalla, MD, Stanford.
AJMC: Osimertinib is an oral drug, whereas amivantamab is an intravenous formulation. Given those differences in delivery mechanisms, how do physicians need to change up workflows for the ...
Although multiple myeloma is often considered incurable, the development of highly effective new therapies is creating a real possibility of a cure for some patients. Current 4-drug upfront regimens, ...
A key barrier in advancing care for ROS1-positive non-small cell lung cancer (NSCLC) is the rarity of the condition, affecting only about 1.5% to 2% of patients. While this still represents a notable ...
Blood-based biomarkers, including neutrophil-to-lymphocyte ratio and circulating tumor DNA, may improve treatment response ...
Using biochemical markers such as estimated glomerular filtration rate (eGFR) and proteinuria improved precision, reaching accuracies near 98% when aligned with kidney disease improving global ...
A wearable device combined with machine learning may offer a solution for continuous cough monitoring in pulmonary fibrosis patients. A wearable cough monitor generated clinically useful cough data, ...
The coexistence of small cell lung cancer (SCLC) and gastrointestinal (GI) malignancies is exceedingly rare. In a new review article in Cureus, investigators outlined 6 such cases and offered insights ...
Pfizer's agreement includes a 3-year grace period to avoid tariffs on drugs manufactured outside the US, with significant discounts on select medications. The Trump administration advances the Most ...
Oncology pharmacists now work alongside providers to improve efficiency, patient education, and treatment outcomes, according to Scott Soefje, PharmD, MBA, BCOP.